(Q28188728)

1

0 references

R J Tawil

2

0 references

L D Engstrom

3

0 references

Z Zeng

4

0 references

C Hwang

5

0 references

M G Sanda

6

0 references

D S Wechsler

7

0 references

language of work or name

English

0 references

publication date

15 May 2001

0 references

published in

The Prostate

0 references

volume

47

0 references

issue

3

0 references

page(s)

194-204

0 references

cites work

Cancer statistics, 1998.

1 reference

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers

21 January 2018

1 reference

Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.

21 January 2018

1 reference

Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone

21 January 2018

1 reference

Oncogene overexpression and de novo drug-resistance in human prostate cancer cells

21 January 2018

1 reference

Transgenic models for the study of prostate cancer

21 January 2018

1 reference

Antisense c-myc retroviral vector suppresses established human prostate cancer

21 January 2018

1 reference

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites

21 January 2018

1 reference

Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity

21 January 2018

1 reference

An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3

21 January 2018

1 reference

Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression

21 January 2018

1 reference

Gene-target recognition among members of the myc superfamily and implications for oncogenesis

21 January 2018

1 reference

Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1

21 January 2018

1 reference

Sequential expression of the MAD family of transcriptional repressors during differentiation and development.

21 January 2018

1 reference

Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q25

21 January 2018

1 reference

Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25

21 January 2018

1 reference

Allelic loss of chromosomes 16q and 10q in human prostate cancer

21 January 2018

1 reference

Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer.

21 January 2018

1 reference

Mutation of the MXI1 gene in prostate cancer

21 January 2018

1 reference

Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth

21 January 2018

1 reference

Isolation of a human prostate carcinoma cell line (DU 145)

21 January 2018

1 reference

Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization

21 January 2018

1 reference

Transfer of genes to humans: early lessons and obstacles to success

21 January 2018

1 reference

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells

21 January 2018

1 reference

Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF.

21 January 2018

1 reference

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

Cdc25 cell-cycle phosphatase as a target of c-myc

21 January 2018

1 reference

Molecular advances in prostate cancer.

21 January 2018

1 reference

Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines

21 January 2018

1 reference

Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein

21 January 2018

1 reference

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer

21 January 2018

1 reference

Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells

21 January 2018

1 reference

Cytogenetic analysis of 57 primary prostatic adenocarcinomas

21 January 2018

1 reference

Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines

21 January 2018

1 reference